We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
-0.54%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.55B
AUM Growth
+$1.66B
Cap. Flow
+$1.48B
Cap. Flow %
41.7%
Top 10 Hldgs %
32.7%
Holding
1,519
New
774
Increased
208
Reduced
176
Closed
301
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BW icon
1026
Babcock & Wilcox
BW
$1.18B
$100K ﹤0.01%
+69,231
New +$83.2K
EVRI
1027
DELISTED
Everi Holdings
EVRI
$99.2K ﹤0.01%
+11,804
New +$96.4K
CMTL icon
1028
Comtech Telecommunications
CMTL
$49.7M
$99.1K ﹤0.01%
+32,700
New +$77.5K
PETS icon
1029
PetMed Express
PETS
$42.3M
$98K ﹤0.01%
+24,200
New +$103K
ADSK icon
1030
Autodesk
ADSK
$51.8B
$98K ﹤0.01%
+396
New +$89K
ATOM icon
1031
Atomera
ATOM
$173M
$97.9K ﹤0.01%
+25,700
New +$121K
PLYA
1032
DELISTED
Playa Hotels & Resorts
PLYA
$97.9K ﹤0.01%
11,667
-17,559
-60% -$155K
OPK icon
1033
Opko Health
OPK
$1.02B
$96.3K ﹤0.01%
+77,000
New +$99.8K
TSE
1034
DELISTED
Trinseo
TSE
$95.1K ﹤0.01%
+41,189
New +$128K
ETR icon
1035
Entergy
ETR
$50.3B
$95K ﹤0.01%
+1,776
New +$95.7K
PLX icon
1036
Protalix BioTherapeutics
PLX
$183M
$92.9K ﹤0.01%
+79,442
New +$93.8K
PDSB icon
1037
PDS Biotechnology
PDSB
$37.4M
$92.4K ﹤0.01%
+31,525
New +$101K
ALNY icon
1038
Alnylam Pharmaceuticals
ALNY
$38.3B
$91.9K ﹤0.01%
378
-2,872
-88% -$453K
SGMT icon
1039
Sagimet Biosciences
SGMT
$435M
$91.3K ﹤0.01%
+26,700
New +$122K
GWH icon
1040
ESS Tech
GWH
$21M
$88K ﹤0.01%
7,173
+4,668
+186% +$52.6K
ACRS icon
1041
Aclaris Therapeutics
ACRS
$715M
$87.1K ﹤0.01%
+79,200
New +$93.1K
OPTN
1042
DELISTED
OptiNose
OPTN
$86.5K ﹤0.01%
+5,543
New +$92.9K
DHX icon
1043
DHI Group
DHX
$177M
$83.8K ﹤0.01%
+40,088
New +$92.9K
LLY icon
1044
Eli Lilly
LLY
$1.08T
$83.3K ﹤0.01%
+92
New +$73.6K
MDB icon
1045
MongoDB
MDB
$25.8B
$83K ﹤0.01%
332
-382
-54% -$121K
MCW
1046
DELISTED
Mister Car Wash
MCW
$82.5K ﹤0.01%
+11,580
New +$81.8K
PGR icon
1047
Progressive
PGR
$128B
$81.6K ﹤0.01%
+393
New +$82.3K
FOSL icon
1048
Fossil Group
FOSL
$260M
$81.6K ﹤0.01%
+56,643
New +$64.3K
MCRB icon
1049
Seres Therapeutics
MCRB
$45M
$80.4K ﹤0.01%
+5,552
New +$92.6K
KVHI icon
1050
KVH Industries
KVHI
$171M
$79.7K ﹤0.01%
+17,143
New +$85.5K

Similar funds

Paloma Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Paloma Partners held 1,519 positions worth $3.55B, up 88% from $1.89B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Paloma Partners deployed $1.48B of net new capital in Q2 2024, opening 774 new positions and adding to 208 existing holdings. Its largest new stake was Invesco QQQ Trust: 58,229 shares worth $27.9M.

By sector, the portfolio is most concentrated in Industrials at 3.8% of assets, up from 3% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P Metals & Mining ETF, an estimated $11M trimmed.

  • Paloma Partners's largest Q2 2024 buy was Invesco QQQ Trust: 58,229 shares worth $27.9M.
  • Paloma Partners added most to ConocoPhillips in Q2 2024, an estimated $12.6M increase.
  • Paloma Partners's biggest Q2 2024 reduction was State Street SPDR S&P Metals & Mining ETF, cutting an estimated $11M.
  • Paloma Partners fully exited Callon Petroleum Company in Q2 2024, selling an estimated $39.2M.
  • Paloma Partners's ten largest holdings make up 33% of its $3.55B portfolio in Q2 2024.
  • Paloma Partners opened 774 new positions and closed 301 in Q2 2024.
  • Paloma Partners's portfolio value rose 88% quarter-over-quarter to $3.55B.

Based on Paloma Partners's 13F filing for Q2 2024, filed 14 Aug 2024.